L-Theanine and the Blood-Brain Barrier: How It Gets Into the Brain and What Happens After It Gets There

L-theanine is an amino acid found naturally in tea leaves, particularly those of the Camellia sinensis plant [1]. Although it has been consumed for centuries in the form of green and black tea, it has attracted considerable scientific interest for its potential effects on relaxation, stress, attention, and cognitive performance [1,2].

One of the most interesting features of L-theanine is its ability to cross the blood-brain barrier (BBB), a highly selective interface that regulates the movement of substances from the circulation into the brain. This is an important property because, for a compound to act directly on the central nervous system, it generally needs to reach its intended targets in sufficient concentrations. However, crossing the BBB is only the beginning of the story.

What happens after L-theanine enters the brain, and how might this explain its effects on our mental state? This article will follow its journey from ingestion to brain activity.

What Is L-Theanine?

L-theanine, chemically known as γ-glutamylethylamide, is a nonproteinogenic amino acid. Unlike amino acids such as leucine or lysine, it is not incorporated into proteins during their synthesis. Its molecular structure is similar to that of glutamate and glutamine, two amino acids with important functions in the nervous system [3,4].

Glutamate is the brain's principal excitatory neurotransmitter, meaning it plays a central role in neuronal communication, learning, memory, and synaptic plasticity. Meanwhile, glutamine is involved in several metabolic processes, including the replenishment of neurotransmitter pools. For a closer look at these pathways, see our guide to GABA and glutamate.

L-theanine's structural resemblance to these molecules is particularly interesting because it helps explain some of its interactions with neurotransmitter transport and signaling systems.

However, L-theanine is not simply another form of glutamate. Its distinct molecular structure gives it different pharmacological properties, including relatively weak interactions with certain glutamate receptors.

The Blood-Brain Barrier: The Brain's Gatekeeper

The brain requires a carefully regulated chemical environment to function properly. Even relatively small disturbances in the concentrations of ions, nutrients, or signaling molecules can influence neuronal activity [5]. The BBB helps maintain this environment. It consists primarily of specialized endothelial cells lining the brain's blood vessels. These cells are connected by tight junctions that substantially restrict the movement of substances between them. Supporting cells, including pericytes and astrocytes, contribute to the regulation and maintenance of the barrier. Consequently, many compounds circulating in the bloodstream cannot simply enter the brain.

Some small, lipid-soluble molecules can cross cell membranes relatively easily, while other substances, including glucose and numerous amino acids, depend on specialized transport proteins. For more background, read our overview of how the blood-brain barrier works.

This is where L-theanine becomes particularly interesting. Despite being a water-soluble amino acid, L-theanine can cross the BBB through a carrier-mediated transport mechanism identified in animal and laboratory studies [6,16].

How Does L-Theanine Cross the Blood-Brain Barrier?

Following oral ingestion, L-theanine is absorbed through the gastrointestinal tract and enters the circulation. In a small human pharmacokinetic study, plasma concentrations reached their maximum approximately 0.8 hours after participants consumed 100 mg of L-theanine, whether delivered in a capsule or green tea [17]. The precise timing may vary with dose and experimental conditions.

Once circulating in the bloodstream, L-theanine can reach the blood vessels supplying the brain. Research in rodents has demonstrated that L-theanine crosses the BBB through a transport system that preferentially carries leucine and other neutral amino acids.

In a foundational study, Yokogoshi and colleagues administered L-theanine to rats and demonstrated its entry into the brain. Their findings implicated a leucine-preferring transport system, providing evidence that L-theanine uses an existing amino acid transport pathway rather than simply diffusing across the barrier [6]. Later cell-based research found that L-theanine can be transported through the system L pathway, including the LAT1 and LAT2 transporter isoforms [16].

This distinction matters because transport proteins regulate the movement of their substrates. Their activity can depend on factors such as substrate concentrations, transporter affinity, and competition with other molecules. It is therefore reasonable to consider whether other amino acids might influence L-theanine transport. However, evidence demonstrating that ordinary dietary variations meaningfully alter L-theanine's brain uptake or behavioral effects in humans remains limited.

Importantly, the specific transporter-level evidence comes predominantly from animal and cell research. Although L-theanine's central nervous system effects are supported by human studies, its precise brain concentrations and transport kinetics following typical human doses have not been characterized directly or as comprehensively.

What Happens After L-Theanine Enters the Brain?

Once L-theanine crosses the BBB, it can interact with several components of the nervous system. Experimental studies suggest that its effects involve multiple neurotransmitter pathways rather than a single molecular target.

Modulating Glutamate Signaling

Because L-theanine resembles glutamate and glutamine structurally, researchers have investigated its interactions with glutamate receptors and transport systems.

Glutamate receptors include several families, notably AMPA, NMDA, and kainate receptors. These receptors participate in excitatory neurotransmission and are essential for processes such as learning and memory.

Preclinical research indicates that L-theanine can interact with certain glutamate receptor subtypes, but with substantially lower affinity than glutamate itself. In one rat cortical-neuron binding study, L-theanine's activity at the tested receptor sites was between 80 and 30,000 times weaker than that of glutamate [18]. L-theanine has also been reported to influence glutamine transport in rat neurons and astroglia, which could indirectly affect the substrates available for neurotransmitter metabolism [19].

These findings are intriguing because excessive glutamatergic activity can contribute to excitotoxicity, a process in which sustained or excessive stimulation damages neurons [7]. Nevertheless, it would be premature to conclude that ordinary L-theanine supplementation meaningfully suppresses glutamate activity or prevents excitotoxic injury in humans.

Much of this mechanistic evidence comes from cellular experiments or animal models, sometimes using concentrations or delivery methods that may not reflect those achieved following typical human consumption.

Influencing GABA and Inhibitory Neurotransmission

Gamma-aminobutyric acid, better known as GABA, is the brain's principal inhibitory neurotransmitter [3,8]. Whereas glutamate generally promotes neuronal excitation, GABA reduces the likelihood that neurons will generate electrical signals.

The interaction between excitatory and inhibitory signaling is essential for normal brain function. Neither system is inherently beneficial or harmful; their coordinated activity helps regulate attention, arousal, sensory processing, and behavior.

Animal studies suggest that L-theanine can influence GABA concentrations and related neurotransmitter pathways [2,9]. This has led to the hypothesis that changes in inhibitory neurotransmission might contribute to L-theanine's reported calming effects.

However, an important distinction is necessary: increasing GABA concentrations or altering GABA-receptor expression in an experimental model does not automatically demonstrate that L-theanine acts as a direct GABA-receptor agonist in humans. In addition, the study cited here used a magnesium-L-theanine preparation as well as L-theanine alone, which limits how specifically its findings can be attributed to conventional L-theanine supplementation [9].

The magnitude and functional significance of changes in human brain GABA following conventional oral supplementation remain uncertain. The available evidence therefore supports GABA-related signaling as a plausible mechanism, rather than a fully established explanation for L-theanine's effects on relaxation.

Effects on Dopamine and Serotonin

L-theanine may also influence neurotransmitters involved in motivation, mood, and behavioral regulation [10].

Dopamine contributes to reward processing, motivation, movement, and several aspects of cognition, whereas serotonin participates in a wide range of functions, including mood regulation, sleep, and appetite.

In a study involving conscious rats, Yokogoshi and colleagues observed changes in brain monoamine concentrations and striatal dopamine release following L-theanine administration [6]. Other animal experiments have reported changes in serotonin-related measures, although the direction and magnitude of these responses have varied.

These findings suggest that L-theanine may affect multiple neurotransmitter systems, potentially in a brain-region-dependent manner.

However, neurotransmitter concentrations alone do not provide a complete picture of neural function. Changes in neurotransmitter synthesis, release, receptor activity, and metabolism can produce different physiological outcomes.

Consequently, claims that L-theanine simply “boosts dopamine” or “increases serotonin” substantially oversimplify the available evidence.

L-Theanine and Brainwave Activity

One of the more interesting aspects of L-theanine research involves its effects on electrical activity in the brain.

Neurons communicate through electrical and chemical signals, and the coordinated activity of large neuronal populations produces oscillations that can be measured using electroencephalography (EEG). These oscillations are commonly categorized according to their frequency.

Alpha activity, generally occurring between approximately 8 and 13 Hz, is often associated with relaxed wakefulness, although its physiological significance depends on the brain region, task, and experimental context.

Several human studies have investigated whether L-theanine influences alpha-band activity. For example, Nobre and colleagues reported a greater increase in alpha activity over time following administration of 50 mg of L-theanine than following placebo in healthy adults [11].

A later randomized, placebo-controlled crossover study investigating a 200 mg dose found greater increases in frontal and whole-scalp alpha power under certain recording conditions, alongside changes in cortisol and self-reported state anxiety during an acute stress challenge [12]. These findings are consistent with the possibility that L-theanine can influence neural activity associated with relaxation.

However, alpha activity should not be interpreted as a direct measurement of relaxation itself. An increase in alpha power does not necessarily mean that someone is calmer, more focused, or cognitively performing better. Indeed, some studies have observed changes in alpha activity without corresponding improvements in every cognitive or subjective outcome.

This distinction highlights why objective neurophysiological measurements and meaningful behavioral outcomes should be considered together.

Does Reaching the Brain Translate Into Measurable Benefits?

The ability of L-theanine to enter the brain provides a plausible biological foundation for its reported effects. But whether those effects translate into meaningful improvements in everyday life requires evidence from controlled human trials.

Clinical studies have examined outcomes including perceived stress, anxiety, attention, sleep quality, and cognitive performance [13,14].

Some trials have reported improvements in selected stress-related measures following acute L-theanine supplementation, while others have investigated longer-term supplementation over several weeks. There is also interest in combining L-theanine with caffeine, particularly because the two compounds may have complementary effects on attention and arousal [15]. You can read more about that combination in our article on GABA and L-theanine.

However, results are not uniformly positive. A 2026 systematic review and meta-analysis of 31 randomized trials found evidence that a single 200 mg dose can improve choice reaction time, but the reduction in acute stress was modest and heavily influenced by studies at high risk of bias. Effects on anxiety were generally inconsistent [20].

Differences in dose, supplementation duration, participant characteristics, experimental tasks, and outcome measurements make it difficult to draw universal conclusions. Moreover, improvements in one domain, such as reaction time or perceived stress, do not necessarily imply improvements in memory, executive function, or overall cognitive performance.

The most defensible interpretation is that L-theanine shows promise for short-term attention and selected aspects of relaxation or stress regulation, while the magnitude and consistency of its effects depend on the population, dose, setting, and outcome measured.

Conclusion

L-theanine offers an interesting example of how a naturally occurring dietary compound can interact with the nervous system. Following ingestion, it is absorbed into the bloodstream and can cross the BBB through an amino acid transport pathway identified primarily in animal and laboratory studies.

Once inside the brain, L-theanine may influence several neurotransmitter systems, including glutamate, GABA, dopamine, and serotonin. Human studies also indicate that it can modify certain patterns of brainwave activity and, under some conditions, measures associated with stress, attention, and relaxation. However, the ability to cross the BBB should not be confused with proof of a particular clinical benefit.

Understanding L-theanine requires connecting several levels of evidence: how it is absorbed and transported, what molecular interactions occur in the brain, and whether these translate into meaningful changes in human physiology and behavior. That connection remains an active area of research. For now, L-theanine is best understood as a biologically active amino acid with plausible central nervous system mechanisms and encouraging, but not universally consistent, evidence for effects on attention, relaxation, stress, and aspects of cognitive function.

 

References

1. Dashwood R, Visioli F. L-theanine: From tea leaf to trending supplement: Does the science match the hype for brain health and relaxation? Nutr Res. 2025;134:39-48. doi:10.1016/j.nutres.2024.12.008.
2. Nathan PJ, Lu K, Gray M, Oliver C. The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006;6(2):21-30.
3. Petroff OAC. GABA and glutamate in the human brain. Neuroscientist. 2002;8(6):562-573. doi:10.1177/1073858402238515.
4. Albrecht J, Sidoryk-Węgrzynowicz M, Zielińska M, Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010;6(4):263-276. doi:10.1017/S1740925X11000093.
5. Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412.
6. Yokogoshi H, Kobayashi M, Mochizuki M, Terashima T. Effect of theanine, γ-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998;23(5):667-673. doi:10.1023/A:1022490806093.
7. Wu W, Gong X, Qin Z, Wang Y. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases: an update. Acta Pharmacol Sin. 2025;46(12):3129-3142. doi:10.1038/s41401-025-01576-w.
8. Bañuelos C, Wołoszynowska-Fraser MU. GABAergic networks in the prefrontal cortex and working memory. J Neurosci. 2017;37(16):3989-3991. doi:10.1523/JNEUROSCI.0135-17.2017.
9. Dasdelen MF, Er S, Kaplan B, et al. A novel theanine complex, Mg-L-theanine, improves sleep quality via regulating brain electrochemical activity. Front Nutr. 2022;9:874254. doi:10.3389/fnut.2022.874254.
10. Wang L, Brennan M, Li S, Zhao H, Lange KW, Brennan C. How does the tea L-theanine buffer stress and anxiety? Food Sci Hum Wellness. 2022;11(3):467-475. doi:10.1016/j.fshw.2021.12.004.
11. Nobre AC, Rao A, Owen GN. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008;17(Suppl 1):167-168.
12. Evans M, McDonald AC, Xiong L, Crowley DC, Guthrie N. A randomized, triple-blind, placebo-controlled, crossover study to investigate the efficacy of a single dose of AlphaWave L-theanine on stress in a healthy adult population. Neurol Ther. 2021;10(2):1061-1078. doi:10.1007/s40120-021-00284-x.
13. Baba Y, Inagaki S, Nakagawa S, Kaneko T, Kobayashi M, Takihara T. Effects of L-theanine on cognitive function in middle-aged and older subjects: a randomized placebo-controlled study. J Med Food. 2021;24(4):333-341. doi:10.1089/jmf.2020.4803.
14. Moulin M, Crowley DC, Xiong L, Guthrie N, Lewis ED. Safety and efficacy of AlphaWave L-theanine supplementation for 28 days in healthy adults with moderate stress: a randomized, double-blind, placebo-controlled trial. Neurol Ther. 2024;13(4):1135-1153. doi:10.1007/s40120-024-00624-7.
15. Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci. 2008;11(4):193-198. doi:10.1179/147683008X301513.
16. Unno T, Suzuki Y, Kakuda T, Hayakawa T, Tsuge H. The involvement of L-type amino acid transporters in theanine transport. Biosci Biotechnol Biochem. 2013;77(3):542-546. doi:10.1271/bbb.120519.
17. Scheid L, Ellinger S, Alteheld B, et al. Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea. J Nutr. 2012;142(12):2091-2096. doi:10.3945/jn.112.166371.
18. Kakuda T, Nozawa A, Sugimoto A, Niino H. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors. Biosci Biotechnol Biochem. 2002;66(12):2683-2686. doi:10.1271/bbb.66.2683.
19. Kakuda T, Hinoi E, Abe A, Nozawa A, Ogura M, Yoneda Y. Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain. J Neurosci Res. 2008;86(8):1846-1856. doi:10.1002/jnr.21637.
20. Gerolymos C, Saddier E, Boyer L, Fond G. Cognitive and affective effects of L-theanine: a systematic review and meta-analysis of 31 randomized trials. Mol Psychiatry. 2026;31(11):6592-6602. doi:10.1038/s41380-026-03727-9.